These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 21083509)

  • 1. Application of human pancreatic carcinoid BON cells for receptor-targeted drug development.
    Sun L; Morris LM; Luo J; Mackey LV; Leslie JS; Franko-Tobin LG; Fuselier JA; LePage KT; Coy DH
    J Drug Target; 2011 Sep; 19(8):666-74. PubMed ID: 21083509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of cancer cell lines for peptide receptor-targeted drug development.
    Sun L; Luo J; Mackey LV; Morris LM; Franko-Tobin LG; LePage KT; Coy DH
    J Drug Target; 2011 Sep; 19(8):719-30. PubMed ID: 21830941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo antitumor effects of cytotoxic camptothecin-bombesin conjugates are mediated by specific interaction with cellular bombesin receptors.
    Moody TW; Sun LC; Mantey SA; Pradhan T; Mackey LV; Gonzales N; Fuselier JA; Coy DH; Jensen RT
    J Pharmacol Exp Ther; 2006 Sep; 318(3):1265-72. PubMed ID: 16766720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Valproic acid induces NET cell growth arrest and enhances tumor suppression of the receptor-targeted peptide-drug conjugate via activating somatostatin receptor type II.
    Sun L; Qian Q; Sun G; Mackey LV; Fuselier JA; Coy DH; Yu CY
    J Drug Target; 2016; 24(2):169-77. PubMed ID: 26211366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatostatin receptor-targeted anti-cancer therapy.
    Sun LC; Coy DH
    Curr Drug Deliv; 2011 Jan; 8(1):2-10. PubMed ID: 21034425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of high affinity camptothecin-bombesin conjugates that have targeted cytotoxicity for bombesin receptor-containing tumor cells.
    Moody TW; Mantey SA; Pradhan TK; Schumann M; Nakagawa T; Martinez A; Fuselier J; Coy DH; Jensen RT
    J Biol Chem; 2004 May; 279(22):23580-9. PubMed ID: 15016826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapy of experimental hepatic cancers with cytotoxic peptide analogs targeted to receptors for luteinizing hormone-releasing hormone, somatostatin or bombesin.
    Szepeshazi K; Schally AV; Treszl A; Seitz S; Halmos G
    Anticancer Drugs; 2008 Apr; 19(4):349-58. PubMed ID: 18454045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel tumor-targeted RGD peptide-camptothecin conjugates: synthesis and biological evaluation.
    Dal Pozzo A; Ni MH; Esposito E; Dallavalle S; Musso L; Bargiotti A; Pisano C; Vesci L; Bucci F; Castorina M; Foderà R; Giannini G; Aulicino C; Penco S
    Bioorg Med Chem; 2010 Jan; 18(1):64-72. PubMed ID: 19942441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New somatostatin-drug conjugates for effective targeting pancreatic cancer.
    Ragozin E; Hesin A; Bazylevich A; Tuchinsky H; Bovina A; Shekhter Zahavi T; Oron-Herman M; Kostenich G; Firer MA; Rubinek T; Wolf I; Luboshits G; Sherman MY; Gellerman G
    Bioorg Med Chem; 2018 Jul; 26(13):3825-3836. PubMed ID: 30017114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy.
    Min KH; Park K; Kim YS; Bae SM; Lee S; Jo HG; Park RW; Kim IS; Jeong SY; Kim K; Kwon IC
    J Control Release; 2008 May; 127(3):208-18. PubMed ID: 18336946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and evaluation of bombesin peptide derivatives as potential tumor imaging agents: effects of structure and composition of amino acid sequence on in vitro and in vivo characteristics.
    Okarvi SM; Jammaz IA
    Nucl Med Biol; 2012 Aug; 39(6):795-804. PubMed ID: 22381782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydroxyethyl starch conjugates for improving the stability, pharmacokinetic behavior and antitumor activity of 10-hydroxy camptothecin.
    Li G; Li Y; Tang Y; Zhang Y; Zhang Y; Yin T; Xu H; Cai C; Tang X
    Int J Pharm; 2014 Aug; 471(1-2):234-44. PubMed ID: 24861941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of camptothecin conjugated to a somatostatin analog vector on growth of tumor cell lines in culture and related tumors in rodents.
    Sun L; Fuselier JA; Coy DH
    Drug Deliv; 2004; 11(4):231-8. PubMed ID: 15371104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and evaluation of a technetium-99m labeled cytotoxic bombesin peptide conjugate for targeting bombesin receptor-expressing tumors.
    Okarvi SM; Al Jammaz I
    Nucl Med Biol; 2010 Apr; 37(3):277-88. PubMed ID: 20346867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanocarrier improves the bioavailability, stability and antitumor activity of camptothecin.
    Tang XJ; Han M; Yang B; Shen YQ; He ZG; Xu DH; Gao JQ
    Int J Pharm; 2014 Dec; 477(1-2):536-45. PubMed ID: 25445532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted tumor theranostics using folate-conjugated and camptothecin-loaded acoustic nanodroplets in a mouse xenograft model.
    Chen WT; Kang ST; Lin JL; Wang CH; Chen RC; Yeh CK
    Biomaterials; 2015; 53():699-708. PubMed ID: 25890765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, in vitro receptor binding, and in vivo evaluation of fluorescein and carbocyanine peptide-based optical contrast agents.
    Achilefu S; Jimenez HN; Dorshow RB; Bugaj JE; Webb EG; Wilhelm RR; Rajagopalan R; Johler J; Erion JL
    J Med Chem; 2002 May; 45(10):2003-15. PubMed ID: 11985468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel delivery of SN38 markedly inhibits tumor growth in xenografts, including a camptothecin-11-refractory model.
    Sapra P; Zhao H; Mehlig M; Malaby J; Kraft P; Longley C; Greenberger LM; Horak ID
    Clin Cancer Res; 2008 Mar; 14(6):1888-96. PubMed ID: 18347192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent and broad antitumor effects of DX-8951f, a water-soluble camptothecin derivative, against various human tumors xenografted in nude mice.
    Kumazawa E; Jimbo T; Ochi Y; Tohgo A
    Cancer Chemother Pharmacol; 1998; 42(3):210-20. PubMed ID: 9685056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, and in vitro evaluation of cytotoxic analogs of bombesin-like peptides containing doxorubicin or its intensely potent derivative, 2-pyrrolinodoxorubicin.
    Nagy A; Armatis P; Cai RZ; Szepeshazi K; Halmos G; Schally AV
    Proc Natl Acad Sci U S A; 1997 Jan; 94(2):652-6. PubMed ID: 9012839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.